Clinical Trials for Muscle Invasive Bladder Urothelial Carcinoma

Find clinical trials for muscle invasive bladder urothelial carcinoma. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

NCT ID: NCT05987241

The MODERN study is a clinical trial designed to explore how a blood test can help identify bladder cancer patients who may need additional treatment after having their bladder surgically removed. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, New Haven, Connecticut, United States +442 more

Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

NCT ID: NCT06809140

This clinical trial is studying a new treatment approach for patients with muscle-invasive bladder cancer (MIBC). Participants will first receive a combination of two medications, enfortumab vedoti...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Indianapolis, Indiana, United States

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

NCT ID: NCT07061964

This clinical trial is studying a new treatment approach for people with muscle invasive bladder cancer, a type of bladder cancer that has grown into the muscle layer of the bladder wall. The goal ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

NCT ID: NCT06396533

The INSITE trial is studying a new way to better identify bladder tumors before surgery. Researchers want to see if combining three tests—looking directly inside the bladder, analyzing blood for tu...

Recruiting

Type: observational Locations: Philadelphia, Pennsylvania, United States

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

NCT ID: NCT06257017

This clinical trial is looking at a new way to guide chemotherapy treatment for patients with muscle-invasive bladder cancer after surgery. Researchers want to see if analyzing a specific genetic s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hong Kong, , Hong Kong

Pan-tumor MRD Study

NCT ID: NCT06605404

The Pan-tumor MRD Study is a clinical trial aimed at improving our understanding of certain types of cancer, including muscle invasive bladder cancer, esophageal cancer, gastric cancer, melanoma, n...

Recruiting

Type: observational Locations: Maumee, Ohio, United States

Drug Screening Using IMD in Bladder Cancer

NCT ID: NCT06204614

This clinical trial is investigating a new way to test cancer drugs for patients with muscle-invasive bladder cancer, which is a type of bladder cancer that has spread into the muscle layer of the ...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Boston, Massachusetts, United States

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

NCT ID: NCT06170177

This clinical trial is looking at how the quality of life and health conditions change for patients who have had a radical cystectomy, which is a surgery to remove the bladder due to bladder cancer...

Recruiting

Type: observational Locations: Milan, Mi, Italy

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions